AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy
Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, ...
Yeti expands board, adds two directors after discussions with activist Engaged
Outdoor goods company Yeti Holdings , which makes cooler boxes and insulated cups, on Monday said it will add two new ...
Fierce Biotech17h
Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic
The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...
BMJ14h
Surgical versus conservative treatment for lumbar disc herniation: a prospective cohort study
Objectives Evidence comparing the effectiveness of surgical and conservative treatment of symptomatic lumbar disc herniation is controversial. We sought to compare short-term and long-term ...